as on February 5, 2026 at 4:02 pm IST
Day's Low
Day's High
3.73%
Downside
2.71%
Upside
52 Week's Low
52 Week's High
12.12%
Downside
55.21%
Upside
as on February 5, 2026 at 4:02 pm IST
Market Cap
₹13.92 Cr
Return on Equity (ROE)
4.23
PE Ratio (TTM)
0Return on capital employed (ROCE)
11.52
Beta (LTM)
0.81
P/B Ratio
1.97
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-60.71
EPS (TTM)
0Sector
Chemicals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Emmessar Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 13.92 | 14.46% | 0.00 | 1 | 1 | |
| NA | 433.38 | -1.95% | 0.51 | 30 | 292 | |
| NA | 216.58 | 25.29% | 0.00 | NA | NA | |
| NA | 87.02 | -3.53% | 0.64 | 5 | 98 | |
| NA | 28.53 | -6.26% | 0.00 | NA | NA |
Get share price movements and forecasts by analysts on Emmessar Biotech.
Source: S&P Global Market Intelligence
Search interest for Emmessar Biotech & Nutrition Ltd Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Emmessar Biotech.
Emmessar Biotech & Nutrition Ltd’s net profit fell -60.71% since last year same period to ₹0.11Cr in the Q2 2025-2026. On a quarterly growth basis, Emmessar Biotech & Nutrition Ltd has generated -35.29% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Emmessar Biotech stock has moved up by 7.1%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 40.28% of holdings in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 59.53% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 160.7% return, outperforming this stock by 144.0%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 29.2% return, outperforming this stock by 60.6%
| Organisation | Emmessar Biotech & Nutrition Ltd |
| Industry | Chemicals |
| CEO | MSR Ayyangar |
| E-voting on shares | Click here to vote |
Emmessar Biotech share price today stands at ₹27.64 as on at the close of the market. Emmessar Biotech share today touched a day high of ₹28.39 and a low of ₹26.61.
Emmessar Biotech touched a 52 week high of ₹42.9 and a 52 week low of ₹24.29. Emmessar Biotech share price today i.e. is closed at ₹27.64, which is -35.57% down from its 52 week high and 13.79% up from its 52 week low.
Emmessar Biotech market capitalisation is ₹13.92 Cr as on .
To buy Emmessar Biotech shares, you need to follow these steps:
Emmessar Biotech trading volume is 788.00 as on . This means that 788.00 shares of Emmessar Biotech were bought and sold on the stock market during today's trading session.